TG Therapeutics IncNASDAQ:TGTX
- LAST PRICE29.5400
- TODAY'S CHANGE (%)-1.3050 (-4.2308%)
- Bid / Lots29.7000/ 2
- Ask / Lots29.9000/ 5
- Open / Previous Close30.7000 / 30.8450
- Day Range
- 52 Week Range
- Volume3,275,262
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TGTX |
|---|---|---|
| 09:32 ET | 64598 | 31.1534 |
| 09:33 ET | 26793 | 30.35 |
| 09:35 ET | 20786 | 30.11 |
| 09:37 ET | 28560 | 29.87 |
| 09:39 ET | 44015 | 29.81 |
| 09:42 ET | 14723 | 29.7222 |
| 09:44 ET | 33613 | 29.73 |
| 09:46 ET | 34924 | 29.385 |
| 09:48 ET | 52838 | 29.33 |
| 09:50 ET | 28433 | 29.385 |
| 09:51 ET | 38475 | 29.3962 |
| 09:53 ET | 36598 | 29.63 |
| 09:55 ET | 12790 | 29.58 |
| 09:57 ET | 13829 | 29.565 |
| 10:00 ET | 11286 | 29.58 |
| 10:02 ET | 29846 | 29.3999 |
| 10:04 ET | 16800 | 29.35 |
| 10:06 ET | 24154 | 29.04 |
| 10:08 ET | 53841 | 29.165 |
| 10:09 ET | 45152 | 29.06 |
| 10:11 ET | 13362 | 29.3 |
| 10:13 ET | 42477 | 29.345 |
| 10:15 ET | 10798 | 29.44 |
| 10:18 ET | 21369 | 29.58 |
| 10:20 ET | 4117 | 29.58 |
| 10:22 ET | 9365 | 29.56 |
| 10:24 ET | 8226 | 29.495 |
| 10:26 ET | 4430 | 29.55 |
| 10:27 ET | 19643 | 29.455 |
| 10:29 ET | 5182 | 29.6128 |
| 10:31 ET | 11019 | 29.63 |
| 10:33 ET | 12922 | 29.6101 |
| 10:36 ET | 6784 | 29.695 |
| 10:38 ET | 13645 | 29.6681 |
| 10:40 ET | 5803 | 29.93 |
| 10:42 ET | 12961 | 29.7956 |
| 10:44 ET | 3643 | 29.64 |
| 10:45 ET | 9141 | 29.53 |
| 10:47 ET | 6500 | 29.49 |
| 10:49 ET | 29673 | 29.54 |
| 10:51 ET | 15789 | 29.7 |
| 10:54 ET | 6721 | 29.495 |
| 10:56 ET | 9512 | 29.42 |
| 10:58 ET | 59364 | 29.145 |
| 11:00 ET | 61070 | 29.2 |
| 11:02 ET | 9262 | 29.3599 |
| 11:03 ET | 52378 | 29.1775 |
| 11:05 ET | 14916 | 29.12 |
| 11:07 ET | 8868 | 29.26 |
| 11:09 ET | 5441 | 29.3 |
| 11:12 ET | 14377 | 29.36 |
| 11:14 ET | 8314 | 29.35 |
| 11:16 ET | 27105 | 29.515 |
| 11:18 ET | 9041 | 29.7 |
| 11:20 ET | 10020 | 29.65 |
| 11:21 ET | 8476 | 29.74 |
| 11:23 ET | 6702 | 29.91 |
| 11:25 ET | 11858 | 29.96 |
| 11:27 ET | 17872 | 29.908 |
| 11:30 ET | 7777 | 29.83 |
| 11:32 ET | 1261 | 29.88 |
| 11:34 ET | 7020 | 29.9411 |
| 11:36 ET | 4829 | 29.89 |
| 11:38 ET | 3254 | 29.8 |
| 11:39 ET | 13213 | 29.86 |
| 11:41 ET | 3752 | 29.815 |
| 11:43 ET | 12853 | 29.76 |
| 11:45 ET | 7212 | 29.73 |
| 11:48 ET | 4825 | 29.79 |
| 11:50 ET | 3147 | 29.785 |
| 11:52 ET | 3166 | 29.77 |
| 11:54 ET | 2020 | 29.9048 |
| 11:56 ET | 1900 | 29.9599 |
| 11:57 ET | 6441 | 29.77 |
| 11:59 ET | 4213 | 29.841 |
| 12:01 ET | 7192 | 29.84 |
| 12:03 ET | 6889 | 29.845 |
| 12:06 ET | 3885 | 29.825 |
| 12:08 ET | 8731 | 29.65 |
| 12:10 ET | 5778 | 29.59 |
| 12:12 ET | 4533 | 29.55 |
| 12:14 ET | 5347 | 29.64 |
| 12:15 ET | 1216 | 29.675 |
| 12:17 ET | 4135 | 29.71 |
| 12:19 ET | 4629 | 29.75 |
| 12:21 ET | 1400 | 29.77 |
| 12:24 ET | 15067 | 29.82 |
| 12:26 ET | 7103 | 29.76 |
| 12:28 ET | 1331 | 29.8048 |
| 12:30 ET | 3257 | 29.86 |
| 12:32 ET | 3424 | 29.82 |
| 12:33 ET | 3237 | 29.76 |
| 12:35 ET | 2912 | 29.77 |
| 12:37 ET | 3912 | 29.68 |
| 12:39 ET | 4186 | 29.6981 |
| 12:42 ET | 3589 | 29.69 |
| 12:44 ET | 13941 | 29.71 |
| 12:46 ET | 5113 | 29.65 |
| 12:48 ET | 4305 | 29.66 |
| 12:50 ET | 5751 | 29.7 |
| 12:51 ET | 4205 | 29.64 |
| 12:53 ET | 785 | 29.66 |
| 12:55 ET | 3426 | 29.58 |
| 12:57 ET | 36872 | 29.615 |
| 01:00 ET | 3367 | 29.5469 |
| 01:02 ET | 9493 | 29.555 |
| 01:04 ET | 4592 | 29.58 |
| 01:06 ET | 5257 | 29.47 |
| 01:08 ET | 3621 | 29.525 |
| 01:09 ET | 3679 | 29.52 |
| 01:11 ET | 2360 | 29.5 |
| 01:13 ET | 2375 | 29.4 |
| 01:15 ET | 39490 | 29.485 |
| 01:18 ET | 4448 | 29.4 |
| 01:20 ET | 7052 | 29.35 |
| 01:22 ET | 1099 | 29.37 |
| 01:24 ET | 1801 | 29.36 |
| 01:26 ET | 1561 | 29.27 |
| 01:27 ET | 3653 | 29.36 |
| 01:29 ET | 5142 | 29.41 |
| 01:31 ET | 2851 | 29.44 |
| 01:33 ET | 2720 | 29.378 |
| 01:36 ET | 2446 | 29.38 |
| 01:38 ET | 3871 | 29.375 |
| 01:40 ET | 5696 | 29.3439 |
| 01:42 ET | 3848 | 29.29 |
| 01:44 ET | 600 | 29.26 |
| 01:45 ET | 6200 | 29.2402 |
| 01:47 ET | 14403 | 29.3001 |
| 01:49 ET | 11613 | 29.2306 |
| 01:51 ET | 2415 | 29.27 |
| 01:54 ET | 1130 | 29.2853 |
| 01:56 ET | 4296 | 29.32 |
| 01:58 ET | 2374 | 29.321 |
| 02:00 ET | 2508 | 29.31 |
| 02:02 ET | 2048 | 29.36 |
| 02:03 ET | 5165 | 29.3079 |
| 02:05 ET | 1772 | 29.24 |
| 02:07 ET | 2839 | 29.29 |
| 02:09 ET | 1767 | 29.39 |
| 02:12 ET | 3205 | 29.41 |
| 02:14 ET | 7043 | 29.36 |
| 02:16 ET | 3192 | 29.34 |
| 02:18 ET | 2100 | 29.26 |
| 02:20 ET | 2151 | 29.32 |
| 02:21 ET | 4651 | 29.26 |
| 02:23 ET | 3723 | 29.3 |
| 02:25 ET | 5077 | 29.28 |
| 02:27 ET | 2813 | 29.29 |
| 02:30 ET | 2311 | 29.26 |
| 02:32 ET | 9624 | 29.28 |
| 02:34 ET | 4769 | 29.36 |
| 02:36 ET | 7303 | 29.41 |
| 02:38 ET | 1735 | 29.4 |
| 02:39 ET | 869 | 29.41 |
| 02:41 ET | 3341 | 29.48 |
| 02:43 ET | 22625 | 29.49 |
| 02:45 ET | 1483 | 29.48 |
| 03:14 ET | 100 | 29.26 |
| 03:15 ET | 5517 | 29.2823 |
| 03:17 ET | 4268 | 29.31 |
| 03:19 ET | 6250 | 29.4 |
| 03:21 ET | 10463 | 29.41 |
| 03:24 ET | 6598 | 29.48 |
| 03:26 ET | 24599 | 29.5 |
| 03:28 ET | 9625 | 29.48 |
| 03:30 ET | 5677 | 29.505 |
| 03:32 ET | 5394 | 29.495 |
| 03:33 ET | 9788 | 29.51 |
| 03:35 ET | 13827 | 29.46 |
| 03:37 ET | 9272 | 29.545 |
| 03:39 ET | 7452 | 29.565 |
| 03:42 ET | 15707 | 29.56 |
| 03:44 ET | 17503 | 29.53 |
| 03:46 ET | 17278 | 29.44 |
| 03:48 ET | 8000 | 29.49 |
| 03:50 ET | 9623 | 29.4208 |
| 03:51 ET | 18964 | 29.4 |
| 03:53 ET | 22601 | 29.425 |
| 03:55 ET | 66448 | 29.57 |
| 03:57 ET | 57724 | 29.705 |
| 04:00 ET | 471721 | 29.54 |
Nov 5, 2024
DJ TG Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 12:51PM ET on Tuesday Nov 05, 2024 by Dow Jones
12:51PM ET on Tuesday Nov 05, 2024 by Dow JonesDJ TG Therapeutics Is Maintained at Neutral by Goldman Sachs, from 12:36PM ET on Tuesday Nov 05, 2024 by Dow Jones
12:36PM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 4, 2024
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI(R) (ublituximab-xiiy) Full Year Revenue Guidance, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones*DJ TG Therapeutics 3Q EPS 2c >TGTX, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update, from 8:06AM ET on Friday Nov 01, 2024 by Dow Jones
8:06AM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TG Therapeutics Inc | 4.6B | -276.9x | --- |
ADMA Biologics Inc | 4.5B | 68.9x | --- |
Axsome Therapeutics Inc | 4.5B | -14.3x | --- |
Arcellx Inc | 4.7B | -122.1x | --- |
Blueprint Medicines Corp | 5.6B | -42.1x | --- |
CRISPR Therapeutics AG | 4.0B | -16.9x | --- |
Company Information
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Contact Information
- Headquarters
- 3020 Carrington Mill Blvd., Suite 475MORRISVILLE, NC, United States 27560-5435
- Phone
- 212-554-4484
- Fax
- 212-554-4531
Executives
- Chairman of the Board, President, Chief Executive Officer
- Michael Weiss
- Chief Financial Officer, Treasurer, Corporate Secretary
- Sean Power
- Lead Independent Director
- Laurence Charney
- Independent Director
- Yann Echelard
- Independent Director
- Kenneth Hoberman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.6B |
|---|---|
Revenue (TTM) | $264.8M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.19 |
EPS | $-0.11 |
Book Value | $1.06 |
P/E Ratio | -276.9x |
Price/Sales (TTM) | 17.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -0.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
